glp-1 agonists for obesity Targeting GLP-1, GIP & GCG in and Type 2 Diabetes Research Science Behind GLP 1 GIP

Established therapeutic approaches have demonstrated efficacy through rigorous clinical trials and should remain the foundation of autoimmune disease management

Eating smaller, more frequent meals and avoiding high-fat foods may help manage gastrointestinal side effects

Marso SP, Bain SC, Consoli A, SUSTAIN-6 Investigators, et al

During Emergency Care: Emergency department physicians and urgent care providers need complete medication lists to make informed decisions

b) Liver Health They reduce fat accumulation in the liver , beneficial for those with non-alcoholic fatty liver disease (NAFLD)

However, these investigations remain inconclusive [6]